Octogen doctrine dealt damaging blow
A decision by a UDRP panellist that again rejects the so-called Octogen line of thinking on bad faith has raised doubts about the sustainability of the doctrine
For a domain to be transferred in a UDRP case there must be evidence that it was both registered and used in bad faith.
In August 2009 Octogen Pharmacal Company vs Domains By Proxy / Rich Sanders and Octogen e-Solutions...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.